Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 1, 2011, Pages 178-184.e7

  Twaroch, Teresa E ^a   Focke, Margit ^a   Civaj, Vera ^a   Weber, Milena ^a   Balic, Nadja ^b   Mari, Adriano ^c   Ferrara, Rosetta ^c   Quirce, Santiago ^d   Spitzauer, Susanne ^b   Swoboda, Ines ^a   Valenta, Rudolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

epitopes; Ole e 1; Olive pollen allergy; peptides; specific immunotherapy

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; KEYHOLE LIMPET HEMOCYANIN; OLE E 1; PEPTIDE VACCINE; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CROSS REACTION; DRUG IDENTIFICATION; DRUG SAFETY; DRUG SYNTHESIS; FEMALE; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; OLIVE; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN BINDING; RABBIT; T LYMPHOCYTE;

EID: 79953657092     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.03.011     Document Type: Article

References (50)

1. A.W. Wheeler Hypersensitivity to the allergens of the pollen from the olive tree (Olea europaea) Clin Exp Allergy 22 1992 1052 1057 (Pubitemid 23011165)
2. J.F. White, and D.I. Bernstein Key pollen allergens in North America Ann Allergy Asthma Immunol 91 2003 425 435
3. M. Lombardero, S. Quirce, O. Duffort, D. Barber, J. Carpizo, and M.J. Chamorro Monoclonal antibodies against Olea europaea major allergen: allergenic activity of affinity-purified allergen and depleted extract and development of a radioimmunoassay for the quantitation of the allergen J Allergy Clin Immunol 89 1992 884 894
4. M. Villalba, E. Batanero, C. López-Otín, L.M. Sánchez, R.I. Monsalve, and M.A. González de la Peña The amino acid sequence of Ole e I, the major allergen from olive tree (Olea europaea) pollen Eur J Biochem 216 1993 863 869 (Pubitemid 23284132)
5. M. Villalba, E. Batanero, R.I. Monsalve, M.A. González de la Peña, C. Lahoz, and R. Rodríguez Cloning and expression of Ole e I, the major allergen from olive tree pollen. Polymorphism analysis and tissue specificity J Biol Chem 269 1994 15217 15222
6. E. Batanero, M. Villalba, and R. Rodríguez Glycosylation site of the major allergen from olive tree pollen. Allergenic implications of the carbohydrate moiety Mol Immunol 31 1994 31 37 (Pubitemid 24076142)
7. E. Martín-Orozco, B. Cárdaba, V. del Pozo, B. de Andrés, M. Villalba, and S. Gallardo Ole e I: epitope mapping, cross-reactivity with other Oleaceae pollens and ultrastructural localization Int Arch Allergy Immunol 104 1994 160 170
8. V. Niederberger, A. Purohit, J.P. Oster, S. Spitzauer, R. Valenta, and G. Pauli The allergen profile of ash (Fraxinus excelsior) pollen: cross-reactivity with allergens from various plant species Clin Exp Allergy 32 2002 933 941 (Pubitemid 34626093)
9. A.J. Castro, J.D. Alché, B. Calabozo, M.I. Rodríguez- García, and F. Polo Pla l 1 and Ole e 1 pollen allergens share common epitopes and similar ultrastructural localization J Investig Allergol Clin Immunol 17 2007 41 47
10. M.J. Pajarón, L. Vila, I. Prieto, A. Resano, M.L. Sanz, and A.K. Oehling Cross-reactivity of Olea europaea with other Oleaceae species in allergic rhinitis and bronchial asthma Allergy 52 1997 829 835 (Pubitemid 27359823)
11. M. Lombardero, T. Obispo, B. Calabozo, A. Lezaún, F. Polo, and D. Barber Cross-reactivity between olive and other species. Role of Ole e 1-related proteins Allergy 57 2002 29 34 (Pubitemid 34442140)
12. R. Barderas, A. Purohit, I. Papanikolaou, R. Rodríguez, G. Pauli, and M. Villalba Cloning, expression, and clinical significance of the major allergen from ash pollen, Fra e 1 J Allergy Clin Immunol 115 2005 351 357 (Pubitemid 40215102)
13. O. Palomares, I. Swoboda, M. Villalba, N. Balic, S. Spitzauer, and R. Rodríguez The major allergen of olive pollen Ole e 1 is a diagnostic marker for sensitization to Oleaceae Int Arch Allergy Immunol 141 2006 110 118 (Pubitemid 44413286)
14. B. Cárdaba, V. Del Pozo, A. Jurado, S. Gallardo, I. Cortegano, and I. Arrieta Olive pollen allergy: searching for immunodominant T-cell epitopes on the Ole e 1 molecule Clin Exp Allergy 28 1998 413 422 (Pubitemid 28215763)
15. E.M. González, M. Villalba, J. Quiralte, E. Batanero, F. Roncal, and J.P. Albar Analysis of IgE and IgG B-cell immunodominant regions of Ole e 1, the main allergen from olive pollen Mol Immunol 43 2006 570 578 (Pubitemid 41785384)
16. E.G. Marazuela, R. Rodríguez, H. Fernández-García, M.S. García, M. Villalba, and E. Batanero Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen Mol Immunol 45 2008 438 445 (Pubitemid 47332650)
17. T.J. Briner, M.C. Kuo, K.M. Keating, B.L. Rogers, and J.L. Greenstein Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I Proc Natl Acad Sci U S A 90 1993 7608 7612 (Pubitemid 23249999)
18. P.S. Norman, J.L. Ohman Jr., A.A. Long, P.S. Creticos, M.A. Gefter, and Z. Shaked Treatment of cat allergy with T-cell reactive peptides Am J Respir Crit Care Med 154 1996 1623 1628 (Pubitemid 26424925)
19. M. Larché, and D.C. Wraith Peptide-based therapeutic vaccines for allergic and autoimmune diseases Nat Med 11 2005 69 76
20. R. Valenta The future of antigen-specific immunotherapy of allergy Nat Rev Immunol 2 2002 446 453 (Pubitemid 37328752)
21. E.G. Marazuela, R. Rodríguez, D. Barber, M. Villalba, and E. Batanero Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines Clin Exp Allergy 37 2007 251 260 (Pubitemid 46148283)
22. M. Focke, V. Mahler, T. Ball, W.R. Sperr, Y. Majlesi, and P. Valent Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination FASEB J 15 2001 2042 2044
23. E. Gasteiger, C. Hoogland, A. Gattiker, S. Duvaud, M.R. Wilkins, and R.D. Appel Protein identification and analysis tools on the ExPASy server J.M. Walker, The proteomics protocols handbook 1st ed. 2005 Humana Press Totowa (NJ) 571 607
24. K.W. Chen, G. Fuchs, K. Sonneck, A. Gieras, I. Swoboda, and N. Douladiris Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering Mol Immunol 45 2008 2486 2498
25. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
26. S. Vrtala, T. Ball, S. Spitzauer, B. Pandjaitan, C. Suphioglu, and B. Knox Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation J Immunol 160 1998 6137 6144 (Pubitemid 28298078)
27. J. Janin Surface and inside volumes in globular proteins Nature 277 1979 491 492
28. M. Focke, I. Swoboda, K. Marth, and R. Valenta Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity Clin Exp Allergy 40 2010 385 397
29. A. Purohit, V. Niederberger, M. Kronqvist, F. Horak, R. Grönneberg, and R. Suck Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives Clin Exp Allergy 38 2008 1514 1525
30. P. Demoly, L. Persi, H. Dhivert, M. Delire, and J. Bousquet Immunotherapy with keyhole limpet hemocyanin-conjugated decapeptide vaccine in cypress pollen allergy Clin Exp Allergy 32 2002 1071 1076 (Pubitemid 34779605)
31. G.W. Siskind, W.E. Paul, and B. Benacerraf Studies on the effect of the carrier molecule on antihapten antibody synthesis. I. Effect of carrier on the nature of the antibody synthesized J Exp Med 123 1966 673 688
32. W.E. Paul, D.H. Katz, E.A. Goidl, and B. Benacerraf Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses J Exp Med 132 1970 283 299
33. N. Mothes, M. Heinzkill, K.J. Drachenberg, W.R. Sperr, M.T. Krauth, and Y. Majlesi Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies Clin Exp Allergy 33 2003 1198 1208 (Pubitemid 37108522)
34. V. Niederberger, F. Horak, S. Vrtala, S. Spitzauer, M.T. Krauth, and P. Valent Vaccination with genetically engineered allergens prevents progression of allergic disease Proc Natl Acad Sci U S A 101 2004 14677 14682 (Pubitemid 39346742)
35. J. Reisinger, F. Horak, G. Pauli, M. van Hage, O. Cromwell, and F. König Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity J Allergy Clin Immunol 116 2005 347 354 (Pubitemid 41096542)
36. G. Pauli, T.H. Larsen, S. Rak, F. Horak, E. Pastorello, and R. Valenta Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis J Allergy Clin Immunol 122 2008 951 960
37. P.A. Würtzen, G. Lund, K. Lund, M. Arvidsson, S. Rak, and H. Ipsen A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation Clin Exp Allergy 38 2008 1290 1301 (Pubitemid 352019667)
38. R.J. Van Neerven, T. Wikborg, G. Lund, B. Jacobsen, A. Brinch-Nielsen, and J. Arnved Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation J Immunol 163 1999 2944 2952 (Pubitemid 29399227)
39. P.A. Wachholz, N.K. Soni, S.J. Till, and S.R. Durham Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy J Allergy Clin Immunol 112 2003 915 922 (Pubitemid 37412059)
40. R.J. Van Neerven, M. Arvidsson, H. Ipsen, S.H. Sparholt, S. Rak, and P.A. Würtzen A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation Clin Exp Allergy 34 2004 420 428 (Pubitemid 38373005)
41. I. Pree, M.H. Shamji, I. Kimber, R. Valenta, S.R. Durham, and V. Niederberger Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules Clin Exp Allergy 40 2010 1346 1352
42. P.S. Creticos, J.T. Schroeder, R.G. Hamilton, S.L. Balcer-Whaley, A.P. Khattignavong, and R. Lindblad Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis N Engl J Med 355 2006 1445 1455 (Pubitemid 44511559)
43. C. Uermösi, R. Beerli, M. Bauer, V. Manolova, K. Dietmeier, and R. Buser Mechanisms of allergen-specific desensitization J Allergy Clin Immunol 126 2010 375 383
44. M. Daëron, O. Malbec, S. Latour, M. Arock, and W.H. Fridman Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors J Clin Invest 95 1995 577 585
45. A.M. Ejrnaes, M. Svenson, G. Lund, J.N. Larsen, and H. Jacobi Inhibition of rBet v 1-induced basophil histamine release with specific immunotherapy-induced serum immunoglobulin G: no evidence that FcgammaRIIB signalling is important Clin Exp Allergy 36 2006 273 282 (Pubitemid 43344708)
46. R. Arnon, and M.H. Van Regenmortel Structural basis of antigenic specificity and design of new vaccines FASEB J 6 1992 3265 3274
47. M. Larché, C.A. Akdis, and R. Valenta Immunological mechanisms of allergen-specific immunotherapy Nat Rev Immunol 6 2006 761 771 (Pubitemid 44453462)
48. J. Edlmayr, K. Niespodziana, B. Linhart, M. Focke-Tejkl, K. Westritschnig, and S. Scheiblhofer A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1 J Immunol 182 2009 6298 6306
49. M. Villalba, E. Batanero, R.I. Monsalve, M.A. González de la Peña, C. Lahoz, and R. Rodríguez Cloning and expression of Ole e I, the major allergen from olive tree pollen. Polymorphism analysis and tissue specificity J Biol Chem 269 1994 15217 15222
50. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685